###begin article-title 0
###xml 26 31 <span type="species:ncbi:9606">Human</span>
CD133 (Prominin) Negative Human Neural Stem Cells Are Clonogenic and Tripotent
###end article-title 0
###begin p 1
Conceived and designed the experiments: YS SMP AS. Performed the experiments: YS WK AF. Analyzed the data: YS WK AF JH SMP AS. Contributed reagents/materials/analysis tools: WK JH LZ AS. Wrote the paper: YS.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
CD133 (Prominin) is widely used as a marker for the identification and isolation of neural precursor cells from normal brain or tumor tissue. However, the assumption that CD133 is expressed constitutively in neural precursor cells has not been examined.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 126 131 <span type="species:ncbi:9606">human</span>
###xml 579 584 <span type="species:ncbi:10090">mouse</span>
###xml 612 617 <span type="species:ncbi:10090">mouse</span>
###xml 637 642 <span type="species:ncbi:9606">human</span>
###xml 832 837 <span type="species:ncbi:9606">human</span>
In this study, we demonstrate that CD133 and a second marker CD15 are expressed heterogeneously in uniformly undifferentiated human neural stem (NS) cell cultures. After fractionation by flow cytometry, clonogenic tripotent cells are found in populations negative or positive for either marker. We further show that CD133 is down-regulated at the mRNA level in cells lacking CD133 immunoreactivity. Cell cycle profiling reveals that CD133 negative cells largely reside in G1/G0, while CD133 positive cells are predominantly in S, G2, or M phase. A similar pattern is apparent in mouse NS cell lines. Compared to mouse NS cells, however, human NS cell cultures harbour an increased proportion of CD133 negative cells and display a longer doubling time. This may in part reflect a sub-population of slow- or non-cycling cells amongst human NS cells because we find that around 5% of cells do not take up BrdU over a 14-day labelling period. Non-proliferating NS cells remain undifferentiated and at least some of them are capable of re-entry into the cell cycle and subsequent continuous expansion.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
The finding that a significant fraction of clonogenic neural stem cells lack the established markers CD133 and CD15, and that some of these cells may be dormant or slow-cycling, has implications for approaches to identify and isolate neural stem cells and brain cancer stem cells. Our data also suggest the possibility that CD133 may be specifically down-regulated during G0/G1, and this should be considered when this marker is used to identify and isolate other tissue and cancer stem cells.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 181 184 181 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Gage1">[1]</xref>
###xml 185 188 185 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Gage2">[5]</xref>
###xml 401 404 401 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Sakakibara1">[6]</xref>
###xml 405 408 405 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Graham1">[9]</xref>
###xml 641 645 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Kawaguchi1">[10]</xref>
###xml 646 650 646 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Roy1">[13]</xref>
###xml 1072 1076 1072 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Capela1">[14]</xref>
###xml 1078 1082 1078 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Solter1">[15]</xref>
###xml 1091 1097 1091 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1220 1224 1220 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Uchida1">[16]</xref>
###xml 1276 1282 1276 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1293 1299 1293 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1390 1394 1390 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Lee1">[17]</xref>
###xml 1396 1400 1396 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Corti1">[18]</xref>
###xml 1531 1539 1531 1539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1544 1551 1544 1551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1551 1555 1551 1555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Uchida1">[16]</xref>
###xml 1556 1560 1556 1560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Corti1">[18]</xref>
###xml 1679 1683 1679 1683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Singh1">[19]</xref>
###xml 1833 1837 1833 1837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Singh2">[20]</xref>
###xml 1838 1842 1838 1842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Yuan1">[22]</xref>
###xml 1942 1946 1942 1946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Singh3">[23]</xref>
###xml 2172 2176 2172 2176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Capela1">[14]</xref>
###xml 2178 2182 2178 2182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Uchida1">[16]</xref>
###xml 2183 2187 2183 2187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Corti1">[18]</xref>
###xml 2306 2310 2306 2310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Pfenninger1">[24]</xref>
###xml 2444 2448 2444 2448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Beier1">[25]</xref>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
###xml 863 868 <span type="species:ncbi:10090">mouse</span>
###xml 1148 1153 <span type="species:ncbi:9606">human</span>
###xml 1352 1357 <span type="species:ncbi:10090">mouse</span>
Findings of continuous neurogenesis in the mammal central nervous system (CNS) have raised great interest in neural stem and progenitor cells in both basic and applied neurobiology [1]-[5]. However, interogation of neural stem cells is hampered by the lack of specific markers. Proteins such as Nestin, Musashi, Sox2, and glial fibrillary acidic protein (GFAP) are expressed in neural precursor cells [6]-[9], but they are also expressed by other cell types. More importantly, intracellular markers cannot be used for prospective stem cell isolation, although in mice this problem may be circumvented by creating transgenic reporter animals [10]-[13]. Recent studies have indicated that certain cell surface markers can be used to locate and enrich neural precursor cells. Capela and Temple (2002) isolated proliferative and neurogenic precursor cells from adult mouse subventricular zone (SVZ) by harvesting cells expressing LeX, a carbohydrate adhesion molecule also known as CD15 (leucocyte cluster of differentiation 15) or SSEA-1 (stage-specific embryonic antigen 1) [14], [15]. Uchida et al. successfully isolated neural precursor cells from human foetal tissue using an antibody directed towards CD133 (Prominin) [16]. CD133 immunopurification was later applied by Lee et al. and Corti et al. to isolate neurosphere forming precursor cells from mouse foetal cerebellum and forebrain [17], [18]. In each of these cases, enriched cells expressed neural stem cell markers and were capable of multi-lineage differentiation both in vitro and in vivo[16]-[18]. Interestingly, CD133 expression could also be detected in a relatively small subpopulation of cells in brain tumours [19]. When these CD133+ cells were isolated, they were able to proliferate, form clonal neurospheres, and produce new tumors after serial transplantation [20]-[22]. CD133 positive cells are therefore considered as candidate cancer stem cells that maintain tumors [23]. Nonetheless, it is not clear whether all neural stem cells or brain cancer stem cells express CD133. Purified CD133+ or CD15+ cells become heterogeneous in neurosphere cultures, but this has been ascribed to differentiation [14], [16]-[18]. However, recent observations indicate that CD133 may not be present on the majority of slow dividing SVZ type B cells[24], considered as adult neural stem cells. Furthermore, tumorigenic cell lines have been derived from CD133 negative glioblastoma cells [25].
###end p 9
###begin p 10
###xml 165 169 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Sun1">[26]</xref>
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Conti1">[27]</xref>
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
###xml 63 68 <span type="species:ncbi:9606">human</span>
We previously reported the establishment of adherent mouse and human neural stem (NS) cell lines that are capable of clonal expansion and tri-potent differentiation [26], [27]. Unlike neurosphere cultures, NS cell lines are purified undifferentiated neural stem cell populations and therefore allow direct investigation of the stem cells. In this manuscript, we examine CD133 and CD15 expression in NS cell lines and the association with potency and cell cycle phase.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human NS cells exhibit heterogeneous CD133 and CD15 expression
###end title 12
###begin p 13
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Sun1">[26]</xref>
###xml 394 398 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Sun1">[26]</xref>
###xml 673 689 673 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g001">Figure 1A and 1B</xref>
###xml 936 948 936 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g001">Figure 1A&#8211;1C</xref>
###xml 1222 1231 1210 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g001">Figure 1D</xref>
###xml 1236 1243 1224 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005498-t001">Table 1</xref>
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 138 143 <span type="species:ncbi:9606">human</span>
###xml 236 241 <span type="species:ncbi:9606">human</span>
###xml 285 290 <span type="species:ncbi:9606">human</span>
###xml 864 869 <span type="species:ncbi:9606">human</span>
###xml 1044 1049 <span type="species:ncbi:9606">human</span>
To determine whether CD133 and CD15 are expressed by human neural stem cells in culture, we performed immunostaining on three independent human NS cell lines, CB541, CB660, and CB660sp [26]. CB541 and CB660 cell lines were derived from human foetal brain, and CB660sp was derived from human foetal spinal cord. All cell lines are maintained in monolayer culture conditions described previously [26]. In the presence of epidermal growth factor (EGF) and fibroblast growth factor 2 (FGF2), these cells remain undifferentiated and express a range of neural precursor and radial glia markers including Nestin, Sox2, Pax6, Vimentin, brain lipid binding protein (BLBP) and 3CB2 (Figure 1A and 1B, and data not shown). These markers are expressed relatively homogeneously throughout the NS cell population. In contrast, immunostaining of live or fixed cells reveals that human NS cells display heterogeneous expression of both CD133 and CD15 (Figure 1A-1C). Flow cytometry analysis confirmed this heterogeneity and showed that, on average, 31+/-2% of human NS cells express CD133 (CD133+/CD15+/-) and 10+/-2% express CD15 (CD133+/-/CD15+). The majority (68+/-2%) of cells do not express either marker, while 8+/-2% express both (Figure 1D and Table 1).
###end p 13
###begin title 14
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human NS cells express CD133 and CD15 heterogeneously.
###end title 14
###begin p 15
###xml 287 288 287 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 309 310 309 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 327 328 327 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 333 334 333 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 390 397 390 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005498-t001">Table 1</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 260 265 <span type="species:ncbi:9606">human</span>
Human NS cells homogeneously express the neural precursor marker Nestin (A and B, red), but exhibit heterogeneous CD133 (A, green) and CD15 (A, green) expression. Live cell staining (C) and subsequent flow cytometry analysis (D) reveal four sub-populations of human NS cells: CD133+/CD15-, CD133+/CD15+, CD133-/CD15+, and CD133-/CD15-. The proportions of each cell population are listed in Table 1.
###end p 15
###begin title 16
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human NS cell lines display heterogeneous CD133 and CD15 expression (%)
###end title 16
###begin p 17
n = 750,000
###end p 17
###begin p 18
###xml 156 157 156 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 162 163 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 176 177 176 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 202 203 202 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 271 280 271 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g002">Figure 2A</xref>
###xml 509 518 507 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g002">Figure 2B</xref>
###xml 643 652 641 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g002">Figure 2B</xref>
###xml 1219 1231 1217 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g002">Figure 2C&#8211;2E</xref>
###xml 1452 1456 1450 1454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Sun1">[26]</xref>
###xml 791 796 <span type="species:ncbi:9606">human</span>
To investigate whether the variation in CD133 and CD15 expression might represent different cell populations in culture, we fractionated NS cells into CD133-/CD15-, CD133+/CD15-, CD133+/CD15+, and CD133-/CD15+ populations by flow cytometry using the gates illustrated in Figure 2A (purity >/=95%). Sorted cells were then cultured in self-renewal conditions in the presence of EGF and FGF2. Each population proliferated and after one week, we found all had re-acquired heterogeneous CD133 and CD15 expression (Figure 2B). When cultures were expanded for another 4 weeks, all four cell populations displayed similar CD133 and CD15 distribution (Figure 2B). In order to verify that CD133 and CD15 expression can switch within cell populations, we performed clonal analysis by depositing single human NS cells from each purified cell fraction. Colonies could be generated from single cells from all four NS cell populations. Immunostaining after 6 weeks expansion shows all NS cell clones exhibit heterogeneous CD133 and CD15 expression (data not shown). When further cultured, these colonies could generate clonal cell lines that were able to produce all three CNS cell types under appropriate differentiation conditions (Figure 2C-2E). The percentages of immunopositive neurons, oligodendrocytes, and astrocytes generated were 40-45%, 1-2%, and over 98% respectively. These values were similar between clones and in the same range as our previous report [26].
###end p 18
###begin title 19
###xml 36 41 <span type="species:ncbi:9606">human</span>
CD133 and CD15 expression varies in human NS cells but is not linked to stem cell potency.
###end title 19
###begin p 20
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human NS cells were flow sorted into four populations using the gates illustrated in (A) and then cultured in NS cell expansion conditions. One week later, each sorted cell population exhibited heterogeneous CD133 and CD15 expression (B). Four weeks later, all four cell populations displayed near-indistinguishable CD133 and CD15 distributions (B). Clonal cultures could also be derived from all four purified cell populations after cell sorting. The cloned cells retained tripotent, being able to generate neurons (Tuj1+) (C), astrocytes (high level GFAP with flattened morphology) (D), and oligodendrocytes (O4+) (E).
###end p 20
###begin p 21
###xml 214 221 214 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005498-t002">Table 2</xref>
###xml 382 383 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 393 394 393 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 516 517 516 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 522 523 522 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 629 634 <span type="species:ncbi:9606">human</span>
The above findings establish that clonogenic human NS cells do not express CD133 or CD15 constitutively. However, we noticed that colony formation efficiency did vary in relation to cell surface marker expression (Table 2). Surprisingly, the lowest frequency was from the double positive CD133+/CD15+ cells, only 3 out of 192 of which generated colonies. From 192 single CD133+/CD15- and CD133-/CD15+ cells, 8 and 4 cells respectively produced colonies. Unexpectedly, the highest efficiency of 15% was from the CD133-/CD15- population. These colonies were morphologically undifferentiated and indistinguishable from the parental human NS cell cultures.
###end p 21
###begin title 22
###xml 48 53 <span type="species:ncbi:9606">human</span>
Colony formation efficiency of single deposited human NS cells
###end title 22
###begin p 23
n =  192
###end p 23
###begin title 24
###xml 51 56 <span type="species:ncbi:9606">human</span>
CD133 expression is regulated at the mRNA level in human NS cells
###end title 24
###begin p 25
###xml 275 279 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Dubreuil1">[28]</xref>
###xml 318 322 318 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/hi</sup>
###xml 332 336 332 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 471 475 471 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 499 503 499 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/hi</sup>
###xml 511 529 511 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g003">Figure 3Aa and 3Ab</xref>
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 337 342 <span type="species:ncbi:9606">human</span>
The above data suggest that CD133 and CD15 expression varies in human NS cell cultures and absence of these markers does not reflect loss of stem cell potency. To investigate whether CD133 expression in NS cells is regulated at the level of transcription or protein shedding [28], we collected mRNA from purified CD133+/hi and CD133-/lo human NS cells. RT-PCR and real-time PCR indicate that prominin/CD133 mRNA expression is down-regulated approximately 30 fold in CD133-/lo cells compared to CD133+/hi cells (Figure 3Aa and 3Ab).
###end p 25
###begin title 26
CD133 expression is regulated at the mRNA level and is reduced in G0/G1 phase.
###end title 26
###begin p 27
###xml 90 94 90 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 149 153 149 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/hi</sup>
###xml 166 170 166 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 180 184 180 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/hi</sup>
###xml 432 436 432 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/hi</sup>
###xml 443 447 443 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 453 457 453 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/hi</sup>
###xml 467 471 467 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 685 689 685 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 785 789 785 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/hi</sup>
###xml 909 912 909 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/hi</sup>
###xml 928 932 928 932 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 1164 1168 1164 1168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/hi</sup>
###xml 1178 1182 1178 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 1323 1327 1323 1327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 1380 1384 1380 1384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/hi</sup>
###xml 95 100 <span type="species:ncbi:9606">human</span>
###xml 291 296 <span type="species:ncbi:9606">human</span>
###xml 850 855 <span type="species:ncbi:9606">human</span>
(A) RT-PCR (Aa) and real-time PCR (Ab) indicate that the expression of CD133 mRNA in CD133-/lo human NS cells is approximately 30 fold lower in CD133+/hi cells. CD133-/lo and CD133+/hi NS cells were purified by cell sorting using the gate illustrated in Ba below. (B) Cell cycle analysis of human NS cells stained with Hoechst 33342, anti-CD133-APC, and anti-CD15-FITC. Analysis gates were set as illustrated in Ba and Be. The CD133+/hi, CD133-/lo, CD15+/hi, and CD15-/lo cells are colored red, green, pink, and blue respectively (Ba-h). Ungated cells are colored black. The cell cycle profile of the entire population is illustrated by dashed lines in Bb and Bf. The majority of CD133-/lo (green) cells were in G1/G0 phase of the cell cycle (Bb and Bc), whereas over half of the CD133+/hi (red) cells were in S, G2, or M phase (Bb and Bd). Although human NS cells express CD15 heterogeneously (Be), the CD15+/hi (pink) and CD15-/lo (blue) cell populations exhibited similar cell cycle profiles, consistent with the whole cell population (Bf-Bh). (C) To test the indication that CD133 may be preferentially down-regulated in cells in G0/G1 phase, we purified CD133+/hi and CD133-/lo cells using the gates illustrated in Ca and applied PI staining after fixation. Flow cytometry analysis indicated that the majority of CD133-/lo cells were in G1/G0 (Cb), whereas over half of CD133+/hi cells had >2N DNA content (Cc).
###end p 27
###begin p 28
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Frey1">[29]</xref>
###xml 290 291 290 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 297 298 297 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 308 309 308 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 322 323 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 573 580 573 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005498-t003">Table 3</xref>
###xml 210 215 <span type="species:ncbi:9606">human</span>
###xml 268 273 <span type="species:ncbi:9606">human</span>
Since the expression of some cell surface markers is related to cell density or cell cycle phase [29], we investigated whether CD133 and CD15 expression may be regulated by these factors. We first investigated human NS cells cultured at different densities. We plated human NS cells at 4x103, 4x104, and 4x105 cells per cm2 respectively and expanded them in the same medium. Immunostaining and flow cytometry analysis performed 2 days later indicated that cells plated at low density exhibited similar heterogeneous distribution of CD133 and CD15 as high density cultures (Table 3).
###end p 28
###begin title 29
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human NS cells plated at different density exhibit similar CD133 and CD15 distribution (%)
###end title 29
###begin p 30
n = 200,000
###end p 30
###begin p 31
###xml 63 67 63 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Latt1">[30]</xref>
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 236 240 236 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 312 326 312 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g003">Figure 3Ba&#8211;3Bd</xref>
###xml 346 350 346 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/hi</sup>
###xml 403 417 403 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g003">Figure 3Ba&#8211;3Bd</xref>
###xml 442 446 442 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/hi</sup>
###xml 455 459 455 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 519 533 519 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g003">Figure 3Be&#8211;3Bh</xref>
###xml 649 653 649 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/hi</sup>
###xml 663 667 663 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 711 721 709 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g003">Figure 3Ca</xref>
###xml 781 785 779 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-ArndtJovin1">[31]</xref>
###xml 787 791 785 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Waring1">[32]</xref>
###xml 849 853 847 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 909 913 907 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/hi</sup>
###xml 941 959 939 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g003">Figure 3Cb and 3Cc</xref>
###xml 147 152 <span type="species:ncbi:9606">human</span>
We next examined cell cycle correlation using Hoechst staining [30]. Based on 1.7x105 scored events, flow cytometry analysis indicates that 65% of human NS cells are in G1/G0, 18% in S phase, and 17% in G2/M phase. We found 91% of CD133-/lo cells have 2N DNA content, constituting 75% of all scored G1/G0 cells (Figure 3Ba-3Bd). Only 31% of CD133+/hi cells were in G1/G0, while 69% were in S, G2, or M (Figure 3Ba-3Bd). In contrast, both CD15+/hi and CD15-/lo NS cells are distributed evenly throughout the cell cycle (Figure 3Be-3Bh). To test the indication that CD133 may be preferentially down-regulated in cells in G0/G1 phase, we purified CD133+/hi and CD133-/lo cells (purity>/=95% and 98% respectively) (Figure 3Ca) and applied propidium iodide (PI) staining after fixation [31], [32]. Flow cytometry analysis indicated that over 88% of CD133-/lo cells were in G1/G0, whereas approximately 65% of CD133+/hi cells had >2N DNA content (Figure 3Cb and 3Cc).
###end p 31
###begin title 32
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
CD133 is also expressed heterogeneously by mouse NS cells
###end title 32
###begin p 33
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Conti1">[27]</xref>
###xml 334 343 334 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g004">Figure 4A</xref>
###xml 581 583 575 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 628 629 622 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 818 822 812 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 884 888 878 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/hi</sup>
###xml 929 945 923 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g004">Figure 4B and 4C</xref>
###xml 152 157 <span type="species:ncbi:10090">mouse</span>
###xml 173 178 <span type="species:ncbi:10090">Mouse</span>
###xml 383 388 <span type="species:ncbi:10090">mouse</span>
###xml 515 520 <span type="species:ncbi:10090">mouse</span>
###xml 691 696 <span type="species:ncbi:10090">mouse</span>
###xml 789 794 <span type="species:ncbi:9606">human</span>
To investigate whether other mammalian neural stem cells express CD133 in a similar pattern, we applied similar staining and flow cytometry analysis to mouse NS cells [27]. Mouse NS cell lines derived either from embryonic stem (ES) cells (CGR8-NS cell line) or foetal cortex (Cor-1 cell line) exhibit heterogeneous CD133 expression (Figure 4A). On average, approximately 46+/-1% of mouse NS cells were immunopositive for CD133, and 54+/-1% of cells negative. Since Hoechst33342 shows considerable toxicity towards mouse NS cells, we applied an alternative dye, Vybrant(R) DyeCycleTM Violet, to analyze cell cycle. Based on 5x105 scored events, flow cytometry analysis indicated that 59% of mouse NS cells reside in G1/G0, 23% in S phase, and 18% in G2/M phase. Similar to observations in human NS cell cultures, CD133-/lo cells were mostly 2N, while just over half (51%) of the CD133+/hi cells have greater than 2N DNA content (Figure 4B and 4C).
###end p 33
###begin title 34
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse NS cells express CD133 heterogeneously.
###end title 34
###begin p 35
###xml 106 110 106 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/lo</sup>
###xml 183 186 183 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/hi</sup>
###xml 5 10 <span type="species:ncbi:10090">mouse</span>
Live mouse NS cells exhibit heterogeneous CD133 expression (A). Flow cytometry indicated that 50% of CD133-/lo cells (green) were in G1/G0 phase, whereas over half (51%) of the CD133+/hi cells (red) were in S, G2, or M phase (B, C).
###end p 35
###begin title 36
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human NS cell cultures may harbour slow-cycling or dormant stem cells
###end title 36
###begin p 37
###xml 122 126 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Sun1">[26]</xref>
###xml 128 132 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Conti1">[27]</xref>
###xml 327 331 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Sun1">[26]</xref>
###xml 892 901 876 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g005">Figure 5A</xref>
###xml 1145 1161 1117 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g005">Figure 5B and 5C</xref>
###xml 1278 1294 1238 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g005">Figure 5B and 5D</xref>
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 83 88 <span type="species:ncbi:10090">mouse</span>
###xml 134 139 <span type="species:ncbi:9606">Human</span>
###xml 238 243 <span type="species:ncbi:9606">human</span>
###xml 478 483 <span type="species:ncbi:9606">human</span>
###xml 752 757 <span type="species:ncbi:10090">mouse</span>
###xml 809 814 <span type="species:ncbi:9606">human</span>
###xml 970 975 <span type="species:ncbi:10090">mouse</span>
###xml 1199 1204 <span type="species:ncbi:9606">human</span>
###xml 1328 1333 <span type="species:ncbi:9606">human</span>
The doubling time of human NS cell cultures (2-3 days) is much longer than that of mouse NS cells (approximately24 hours) [26], [27]. Human NS cells also exhibit a higher percentage of CD133 negative cells that are mostly in G1/G0. Since human NS cell cultures do not express differentiation markers under expansion conditions [26], the longer doubling time is unlikely to be due to NS cell differentiation into non-proliferative cell lineages. We speculated that a fraction of human NS cells may spontaneously withdraw from the cell cycle (entering G0) which could contribute to a prolonged doubling time. We performed immunostaining against Ki67, a nuclear protein expressed by proliferating cells in all cell cycle phases. We found 79.68+/-2.40% of mouse NS cells expressed Ki67, but only 53.48+/-6.62% of human NS cells exhibited Ki67 immunoreactivity under identical culture conditions (Figure 5A). Bromo-deoxyuridine (BrdU) incorporation experiments revealed that mouse NS cell cultures contained a higher percentage of BrdU labelled cells at all checked time points, reaching a plateau close to 100% after approximately3 days incubation (Figure 5B and 5C). In contrast, the fraction of BrdU+ human NS cells began to level off at approximately95% after 4 days incubation (Figure 5B and 5D). This suggests that up to 5% of human NS cells may be slow-dividing or non-dividing, although they have not differentiated into neurons or glia.
###end p 37
###begin title 38
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Human NS cell cultures propagate more slowly than mouse counterparts.
###end title 38
###begin p 39
###xml 339 348 339 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g005">Figure 5D</xref>
###xml 12 17 <span type="species:ncbi:10090">mouse</span>
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 164 169 <span type="species:ncbi:10090">mouse</span>
###xml 249 254 <span type="species:ncbi:9606">human</span>
###xml 372 377 <span type="species:ncbi:9606">human</span>
Compared to mouse NS cell cultures, human NS cell cultures exhibit a lower percentage of Ki67 expressing cells under the same expansion conditions (A). Over 99% of mouse NS cells incorporated BrdU after 5 days incubation (B, C). Approximately 5% of human NS cells remained BrdU negative after prolonged incubation (B, D). Yellow arrows in Figure 5D indicate BrdU negative human NS cells after 10 days incubation.
###end p 39
###begin p 40
###xml 151 155 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Shapiro1">[33]</xref>
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Ladd1">[34]</xref>
###xml 362 366 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Azuma1">[35]</xref>
###xml 368 372 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Doetsch2">[36]</xref>
###xml 621 637 618 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g006">Figure 6A and 6B</xref>
###xml 811 827 808 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g006">Figure 6C and 6D</xref>
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 228 233 <span type="species:ncbi:9606">human</span>
###xml 238 243 <span type="species:ncbi:10090">mouse</span>
###xml 395 400 <span type="species:ncbi:9606">human</span>
###xml 431 436 <span type="species:ncbi:9606">human</span>
To test the hypothesis that human NS cell cultures may harbour dormant or slow-dividing cells, we attempted double staining with Hoechst and Pyronin Y [33], [34]. However, this combination proved extremely toxic and over 99% of human and mouse NS cells died after staining. We therefore applied the antimitotic drug cytosine-beta-d-arabinofuranoside (Ara-c, 2%) [35], [36] to eliminate dividing human NS cells. Approximately 5% of human NS cells remained viable after 5 days Ara-c treatment. Immunostaining showed these cells retained Nestin and Sox2 expression, but they were not positive for CD133, Ki67, or Caspase-3 (Figure 6A and 6B, and data not shown). Upon re-plating without Ara-c and culturing for 10 days in EGF and FGF, approximately 15% of cells displayed Ki67 expression and 8.7% expressed CD133 (Figure 6C and 6D). When further cultured, these cells expanded continuously and could differentiate as other NS cells (data not shown).
###end p 40
###begin title 41
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human NS cell cultures harbour slow-cycling or dormant cells.
###end title 41
###begin p 42
###xml 20 25 <span type="species:ncbi:9606">human</span>
Approximately 5% of human NS cells remained viable after 5 days exposure to the antimitotic drug Ara-c. The viable cells retained Nestin and Sox2 expression but did not express Ki67 or CD133 (A, B). When these cells were re-plated into medium without Ara-c for 10 days, approximately 14.6% of cells expressed Ki67 and 8.7% expressed CD133 (C, D). Yellow arrows in (C) indicate Ki67 positive cells.
###end p 42
###begin title 43
Discussion
###end title 43
###begin p 44
###xml 165 169 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Capela1">[14]</xref>
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Uchida1">[16]</xref>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Corti1">[18]</xref>
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Capela2">[37]</xref>
###xml 329 337 329 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 459 463 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Suslov1">[38]</xref>
###xml 464 468 464 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Ostenfeld1">[40]</xref>
###xml 512 516 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Sun1">[26]</xref>
###xml 1202 1206 1202 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Jaksch1">[41]</xref>
###xml 492 497 <span type="species:ncbi:9606">human</span>
Cell surface markers CD133 and CD15 have been recognized as neural stem cell markers and have been applied to enrich for neural precursor cells from various sources [14], [16]-[18], [37]. However, to our knowledge, purified CD133 or CD15 expressing neural precursor cells have not been maintained as homogeneous cell populations in vitro. In neurosphere cultures this is obscured because neural precursor cells spontaneously differentiate into glial lineages [38]-[40]. By analyzing purified human NS cell lines [26], we find CD133 and CD15 are only expressed by a subpopulation of neural stem cells. We demonstrated that single CD133 and/or CD15 negative cells could generate clonal and tripotent neural stem cell lines. The two cell surface markers were invariably expressed heterogeneously in proliferating cultures. Therefore cultured neural stem cells are not constitutively CD133 or CD15 positive. This could be related to the observation that CD133 expression appears linked to cell cycle phase in NS cells. CD133 negative cells are disproportionately represented in G0/G1. Recently, cell cycle dependent variation in CD133 expression has been described for colon cancer and melanoma cell lines [41]. These authors also find that CD133 levels are down-regulated in G0-G1, suggesting that this may be a generic feature.
###end p 44
###begin p 45
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Uchida1">[16]</xref>
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 169 174 <span type="species:ncbi:9606">human</span>
In our adherent culture conditions CD133 negative human NS cells exhibited higher colony formation efficiency than CD133 positive cells. Previous analyses using primary human foetal CNS tissue have indicated that few or even no neurospheres could be derived from CD133 negative cell populations [16]. However, primary tissues contain overwhelming numbers of differentiated cells that are CD133 negative. Therefore CD133 sorting will give a major enrichment even if only capturing a fraction of the stem cells. It is also possible that CD133 negative stem cells may not initiate colony formation in suspension culture, even though they do so efficiently when adherent. The higher cloning efficiency we observed for CD133 negative versus CD133 positive cells might be because G0/G1 cells are intrinsically more clonogenic, or they may be less fragile and more resistant to flow sorting compared cells in S, G2, or M phase. Alternatively they may have some other feature that resists stress-induced differentiation or promotes attachment.
###end p 45
###begin p 46
###xml 411 420 411 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005498-g005">Figure 5B</xref>
###xml 24 29 <span type="species:ncbi:9606">human</span>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 180 185 <span type="species:ncbi:10090">mouse</span>
###xml 283 288 <span type="species:ncbi:9606">human</span>
###xml 360 365 <span type="species:ncbi:9606">human</span>
###xml 469 474 <span type="species:ncbi:10090">mouse</span>
###xml 757 762 <span type="species:ncbi:9606">human</span>
###xml 1067 1072 <span type="species:ncbi:9606">human</span>
Interestingly, although human and mouse NS cells are cultured under identical conditions, human NS cell cultures harbour fewer CD133+ cells and exhibit a longer doubling time than mouse counterparts. Ki67 staining and BrdU incorporation experiments indicated that a subpopulation of human NS cells may withdraw from the cell cycle. The fraction of non-cycling human NS cells, estimated from BrdU incorporation (Figure 5B) is around 5% whereas this is less than 0.2% in mouse NS cell cultures. These non-cycling cells do not show features of differentiation or senescence, and retain precursor markers suggesting they could be dormant stem cells. To investigate further we applied Ara-c, an antimitotic drug, to eliminate dividing cells. Approximately 5% of human NS cells remained viable. These cells retained Nestin and Sox2 expression but did not express CD133 or Ki67. Parallel BrdU labelling confirmed they were not dividing. Crucially however, a proportion of these cells resumed proliferation after the antimitotic drug was removed. This strongly suggests that human NS cells in culture can suspend proliferation but retain the capacity to re-enter the cell cycle.
###end p 46
###begin p 47
###xml 95 99 95 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Pollard1">[44]</xref>
###xml 209 213 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Singh1">[19]</xref>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Singh2">[20]</xref>
###xml 310 314 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Singh1">[19]</xref>
###xml 610 618 610 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 618 622 618 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Pollard1">[44]</xref>
###xml 659 664 <span type="species:ncbi:9606">human</span>
A major interest in neural stem cell biology is the relationship with brain tumor cells [42,43 [44]]. CD133 has been successfully applied to isolate brain tumor initiating cells, also called cancer stem cells [19], [20]. It was found that malignant brain tumors have a higher CD133 index than low-grade tumors [19]. Based on the present observations, however, this does not necessarily indicate an increased frequency of stem cells but may reflect a higher proliferative index in the stem cell compartment. Indeed we have found that glioblastoma stem cells also exhibit heterogeneous CD133 and CD15 expression in vitro[44], similar to the profile observed in human NS cells. If CD133 expression in brain cancer stem cells is regulated in a cell cycle dependent fashion, extra caution must be taken when this marker is used to define tumour stem cells. This would be particularly significant if CD133 is not expressed by quiescent brain cancer stem cells.
###end p 47
###begin p 48
###xml 483 490 483 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
In conclusion, our data demonstrate that mammalian neural stem cells are not constitutively CD133 or CD15 positive, and that down-regulation of CD133 protein and mRNA correlates with an enrichment of cells in G0-G1 phase of the cell cycle. These observations point to the potential absence of CD133 expression in slow-cycling or dormant neural stem cells. It will be informative to investigate whether CD133 expression is similarly down-regulated in G0/G1 in adult neural stem cells in vivo. The mechanisms and regulation of NS cell dormancy are also of interest for future study.
###end p 48
###begin title 49
Methods
###end title 49
###begin title 50
Cell culture
###end title 50
###begin p 51
###xml 64 68 64 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Sun1">[26]</xref>
###xml 73 77 73 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Conti1">[27]</xref>
###xml 952 956 952 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Sun1">[26]</xref>
###xml 961 965 961 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005498-Conti1">[27]</xref>
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
###xml 91 96 <span type="species:ncbi:9606">human</span>
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
###xml 271 276 <span type="species:ncbi:10090">mouse</span>
###xml 320 325 <span type="species:ncbi:9606">human</span>
The derivation of human and mouse NS cell lines is described in [26] and [27]. Established human and mouse NS cell lines are cultured on laminin (10 mg/L, Sigma) coated dishes (Iwaki) in expansion medium comprising RHB-A medium (Stem Cell Sciences Ltd., UK), recombinant mouse EGF (10 ng/ml, Peprotech), and recombinant human FGF-2 (10 ng/ml, Peprotech). Expansion medium was changed every 2 days. Cells were detached and split 1:2 to 1:3 using Accutase (Sigma) once cultures became confluent. Clonal NS cell lines were generated by deposition of single cells into laminin coated 96-well plates using a Dako Cytomation MoFlo cell sorter. The presence of single cells was checked under a bright field microscope after sorting. Culture medium was renewed by 50% change every 3 days for clonal expansion. Clones were passaged after 4 weeks. Differentiation protocols for generating neurons, astrocytes, and oligodendrocytes from NS cells are described in [26] and [27].
###end p 51
###begin title 52
Immunostaining
###end title 52
###begin p 53
For intracellular staining, cells were fixed with 4% PFA for 15 minutes at room temperature followed by 30 minutes incubation with BLOCK solution. Each 100 ml BLOCK solution contained 97 ml PBS, 3 ml serum, and 0.1% Triton-X100. Cells were then incubated with primary antibodies for 2 hours at room temperature or overnight at 4degreesC. We used Alexa-Fluor secondary conjugates (Invitrogen) and DAPI (Sigma) to visualize the staining. Primary antibodies were used at the following dilutions: Nestin (1:500; R&D Systems), Sox2 (1:400; Chemicon), GFAP (1:300; Millipore), Tuj1 (1:200, Covance), 3CB2 (1:20, DSHB), BLBP (1:500, Abcam), Vimentin (1:20, DSHB), and Ki67 (1:250, Lab Vision).
###end p 53
###begin p 54
###xml 362 367 <span type="species:ncbi:9606">human</span>
###xml 404 409 <span type="species:ncbi:10090">mouse</span>
###xml 441 446 <span type="species:ncbi:9606">human</span>
To stain live cells, cultured cells were incubated with primary antibody in serum-free expansion medium for 15 minutes at room temperatures followed by 3 washes with medium. Staining was visualized by incubation with Alexa-Fluor secondary conjugates (Invitrogen) for 10 minutes at room temperatures. Primary antibodies were used at the following dilutions: anti-human CD133 (1:10, Miltenyi Biotec), anti-mouse CD133 (1:5, eBioscience), anti-human CD15 (1:10, Miltenyi Biotec), and anti-O4 (1:100, R&D Systems). Live stained cells could subsequently be fixed and stained with further antibodies.
###end p 54
###begin p 55
For BrdU assays, NS cells were plated into 12-well plates with expansion medium and were incubated at 37degreesC overnight for recovery. Cells were then expanded in the presence of 10 microM BrdU (Sigma). Cells were fixed in 4% paraformaldehyde at different time points. After fixation, we added 500 microl of 2M HCl into each well and left at room temperature for one hour. Cells were then stained with anti-BrdU antibody (Sigma) using protocols described above.
###end p 55
###begin title 56
Semi-quantitative and real-time RT-PCR
###end title 56
###begin p 57
###xml 570 599 546 575 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTC TTC CCC TCC ATC GTG-3&#8242;</named-content>
###xml 627 659 600 632 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGG TGT GGT GCC AGA TTT TC-3&#8242;</named-content>
###xml 682 714 655 687 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAG AGT ACA ACG CCA AAC CA-3&#8242;</named-content>
###xml 737 769 710 742 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAA TCA CGA TGA GGG TCA GC-3&#8242;</named-content>
We used RNeasy kit (Qiagen) to extract total RNA and Superscript III (Invitrogen) to prepare cDNA. cDNA concentrations were determined and normalized by NanoDrop-1000 (Thermo Scientific). RT-PCR was performed for 30 cycles for all markers except beta-actin for 25 cycles (denaturing for 40 s at 94degreesC; annealing for 40 s at 56degreesC, extension for 60 s at 72degreesC). PCR products were resolved on 1.5% agarose gel. Real-time PCR was carried out using a LightCycler (Roche). Primers were designed using MIT Primer3 software as follows: beta-actin forward primer 5'-GTC TTC CCC TCC ATC GTG-3', beta-actin reverse primer 5'-AGG TGT GGT GCC AGA TTT TC-3', CD133 forward primer 5'-CAG AGT ACA ACG CCA AAC CA-3', CD133 reverse primer 5'-AAA TCA CGA TGA GGG TCA GC-3'.
###end p 57
###begin title 58
Flow cytometry and cell sorting
###end title 58
###begin p 59
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 114 119 <span type="species:ncbi:10090">mouse</span>
###xml 166 171 <span type="species:ncbi:9606">human</span>
Single-cell suspensions were stained with antibodies against human CD133 (1:10, APC conjugated, Miltenyi Biotec), mouse CD133 (1:5, APC conjugated, eBioscience), and human CD15 (1:10, FITC conjugated, Miltenyi Biotec). Dead cells were excluded using forward and side scatter as well as the vital dye Topro-3 (Molecular Probes) or 7AAD (BD). Typically 1 million cells were stained in an eppendorf tube. Antibodies were added into serum-free medium and incubated in the dark for 15 minutes at room temperatures. Cells were then centrifuged and washed 3 times in medium prior to analysis or sorting. Flow cytometry analysis was carried out on a CyAn ADP analyzer (Beckman). Cell sorting was performed using a MoFlo sorter (Dako Cytomation). Matched isotype antibodies were applied in parallel as controls.
###end p 59
###begin p 60
Cell cycle was analyzed using two methods. For live NS cells, a single cell suspension containing approximately 1 million cells was incubated with 0.5 microg Hoechst 33342 (Invitrogen) or 0.5 microg Vybrant DyeCycle Violet (Invitrogen) at 37degreesC for 30 minutes in 1 ml medium. Alternatively, the cell suspension was fixed in 70% ethanol at -20degreesC for 15 minutes. Cells were then centrifuged and incubated in 5 ml PBS at room temperature for 15 minutes. Finally, approximately 1 million cells were transferred to PBS containing 0.5 mg/ml propidium iodide (Invitrogen) and 1 mg/ml RNAse (Sigma). Cell cycle analysis was carried out on a CyAn ADP analyzer (Beckman) and using Flowjo software (Tree Star, Inc). CD133/CD15 staining was performed on live cells before Hoechst and propidium iodide staining in cases of triple staining.
###end p 60
###begin p 61
We thank Rachael Walker for supporting flow cytometry studies.
###end p 61
###begin title 62
References
###end title 62
###begin article-title 63
Multipotent progenitor cells in the adult dentate gyrus.
###end article-title 63
###begin article-title 64
Stem cells and neurogenesis in the adult brain.
###end article-title 64
###begin article-title 65
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
Neurogenesis persists in the subependymal layer of the adult mouse brain.
###end article-title 65
###begin article-title 66
Neurogenesis in adult subventricular zone.
###end article-title 66
###begin article-title 67
Mammalian neural stem cells.
###end article-title 67
###begin article-title 68
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse-Musashi-1, a neural RNA-binding protein highly enriched in the mammalian CNS stem cell.
###end article-title 68
###begin article-title 69
Subventricular zone astrocytes are neural stem cells in the adult mammalian brain.
###end article-title 69
###begin article-title 70
###xml 127 132 <span type="species:ncbi:10090">mouse</span>
Sox2 regulatory sequences direct expression of a (beta)-geo transgene to telencephalic neural stem cells and precursors of the mouse embryo, revealing regionalization of gene expression in CNS stem cells.
###end article-title 70
###begin article-title 71
SOX2 functions to maintain neural progenitor identity.
###end article-title 71
###begin article-title 72
###xml 12 27 <span type="species:ncbi:10090">transgenic mice</span>
Nestin-EGFP transgenic mice: visualization of the self-renewal and multipotency of CNS stem cells.
###end article-title 72
###begin article-title 73
Genetic and functional differences between multipotent neural and pluripotent embryonic stem cells.
###end article-title 73
###begin article-title 74
###xml 133 137 <span type="species:ncbi:10090">mice</span>
Screening for mammalian neural genes via fluorescence-activated cell sorter purification of neural precursors from Sox1-gfp knock-in mice.
###end article-title 74
###begin article-title 75
###xml 66 71 <span type="species:ncbi:9606">human</span>
In vitro neurogenesis by progenitor cells isolated from the adult human hippocampus.
###end article-title 75
###begin article-title 76
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal.
###end article-title 76
###begin article-title 77
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1).
###end article-title 77
###begin article-title 78
###xml 20 25 <span type="species:ncbi:9606">human</span>
Direct isolation of human central nervous system stem cells.
###end article-title 78
###begin article-title 79
Isolation of neural stem cells from the postnatal cerebellum.
###end article-title 79
###begin article-title 80
###xml 34 40 <span type="species:ncbi:10090">murine</span>
Isolation and characterization of murine neural stem/progenitor cells based on Prominin-1 expression.
###end article-title 80
###begin article-title 81
###xml 40 45 <span type="species:ncbi:9606">human</span>
Identification of a cancer stem cell in human brain tumors.
###end article-title 81
###begin article-title 82
###xml 18 23 <span type="species:ncbi:9606">human</span>
Identification of human brain tumour initiating cells.
###end article-title 82
###begin article-title 83
Cancerous stem cells can arise from pediatric brain tumors.
###end article-title 83
###begin article-title 84
Isolation of cancer stem cells from adult glioblastoma multiforme.
###end article-title 84
###begin article-title 85
Cancer stem cells in nervous system tumors.
###end article-title 85
###begin article-title 86
CD133 is not present on neurogenic astrocytes in the adult subventricular zone, but on embryonic neural stem cells, ependymal cells, and glioblastoma cells.
###end article-title 86
###begin article-title 87
CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
###end article-title 87
###begin article-title 88
###xml 48 53 <span type="species:ncbi:9606">human</span>
Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture.
###end article-title 88
###begin article-title 89
Niche-independent symmetrical self-renewal of a mammalian tissue stem cell.
###end article-title 89
###begin article-title 90
Midbody and primary cilium of neural progenitors release extracellular membrane particles enriched in the stem cell marker prominin-1.
###end article-title 90
###begin article-title 91
Surface expression of gpA33 is dependent on culture density and cell-cycle phase and is regulated by intracellular traffic rather than gene transcription.
###end article-title 91
###begin article-title 92
Spectral studies on 33258 Hoechst and related bisbenzimidazole dyes useful for fluorescent detection of deoxyribonucleic acid synthesis.
###end article-title 92
###begin article-title 93
Fluorescence labeling and microscopy of DNA.
###end article-title 93
###begin article-title 94
Complex formation between ethidium bromide and nucleic acids.
###end article-title 94
###begin article-title 95
Flow cytometric estimation of DNA and RNA content in intact cells stained with Hoechst 33342 and pyronin Y.
###end article-title 95
###begin article-title 96
###xml 117 122 <span type="species:ncbi:9606">human</span>
Orderly process of sequential cytokine stimulation is required for activation and maximal proliferation of primitive human bone marrow CD34+ hematopoietic progenitor cells residing in G0.
###end article-title 96
###begin article-title 97
2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine: a novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrest.
###end article-title 97
###begin article-title 98
Regeneration of a germinal layer in the adult mammalian brain.
###end article-title 98
###begin article-title 99
LeX is expressed by principle progenitor cells in the embryonic nervous system, is secreted into their environment and binds Wnt-1.
###end article-title 99
###begin article-title 100
Neural stem cell heterogeneity demonstrated by molecular phenotyping of clonal neurospheres.
###end article-title 100
###begin article-title 101
Neural stem cells and neurospheres-re-evaluating the relationship.
###end article-title 101
###begin article-title 102
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation.
###end article-title 102
###begin article-title 103
###xml 53 58 <span type="species:ncbi:9606">human</span>
Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines.
###end article-title 103
###begin article-title 104
Making a tumour's bed: glioblastoma stem cells and the vascular niche.
###end article-title 104
###begin article-title 105
The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
###end article-title 105
###begin article-title 106
Glioma stem cell lines expanded in adherent culture have tumour-specific phenotypes and are suitable for chemical and genetic screens.
###end article-title 106
###begin p 107
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 107
###begin p 108
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The study was funded by European Commission projects, StemStroke and EuroSyStem, the Biotechnology and Biological Sciences Research Council and the Medical Research Council of the United Kingdom, the National Natural Science Foundation of China, the Scientific Research Foundation for the Returned Overseas Chinese Scholars, the State Education Ministry (China), and Shanghai Pujiang Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AS is a Medical Research Council Professor.
###end p 108

